Market Overview

Source Familiar with Matter Attributes Downside in Global Blood Therapeutics to Investor Concern Co. May Have Needed to Move Timeline of Drug Impact for Primary Endpoint on GBT440 from ~1 Month to ~6 Months

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News Rumors FDA Market-Moving Exclusives Movers

 

Related Articles (GBT)